Healthcare Purchasing News
  • Magazine
  • Continuing Education
  • Webinars
  • Whitepapers
  • Videos
  • Events
  • Hall of Fame
  • Advertise
  • Source Guide
  • Subscribe
  • Sourcing & Logistics
  • Sterile Processing
  • Surgical & Critical Care
  • Patient Satisfaction
  • Infection Prevention
  • EVS & Facility Services
  • Healthcare IT
  • Regulatory
  • Topics
    Sourcing & LogisticsSterile ProcessingSurgical & Critical CarePatient SatisfactionInfection PreventionEVS & Facility ServicesHealthcare ITRegulatory
    Resources
    HPN Source GuideContinuing EducationWebinarsWhitepapersVideosEventsHall of FameAdvertiseAd Specs
    User Tools
    SubscribeContact UsAbout UseNewsletterMagazinesPrivacy PolicyTerms & Conditions
    https://www.facebook.com/hpnonline
    https://www.linkedin.com/company/healthcare-purchasing-news/
    https://twitter.com/HPN_Online
    1. Sourcing & Logistics

    Pfizer acquires Global Blood Therapeutics

    Oct. 6, 2022
    Illustration 96969952 © Alexey Novikov | Dreamstime.com
    Dreamstime Xs 96969952

    Pfizer Inc. announced the completion of its acquisition of Global Blood Therapeutics, Inc. (GBT), a biopharmaceutical company dedicated to the discovery, development and delivery of life-changing treatments that provide hope to underserved patient communities starting with sickle cell disease (SCD). The acquisition reinforces Pfizer’s commitment to SCD, building on a 30-year legacy in the rare hematology space.

    GBT brings a portfolio and pipeline that has the potential to address the full spectrum of critical needs for this underserved community. GBT discovered and developed Oxbryta (voxelotor), a first-in-class medicine that directly targets the root cause of SCD. In addition, GBT’s promising pipeline of preclinical and clinical investigational assets focused in SCD includes GBT021601 (GBT601) and inclaclumab, both of which have received Orphan Drug and Rare Pediatric Disease designations from the U.S. Food and Drug Administration (FDA).

    “With Global Blood Therapeutics’ talent, portfolio, and pipeline now part of Pfizer, we look forward to accelerating innovation and expeditiously bringing multiple potential best-in-class treatments to people living with sickle cell disease,” said Aamir Malik, Chief Business Innovation Officer, Executive Vice President, Pfizer. “In line with our value of equity, Pfizer is committed to addressing the underserved needs of the sickle cell disease community. We are excited about these potential breakthroughs and the opportunity to transform the lives of these patients.”

    SCD is a lifelong, devastating inherited blood disorder impacting millions of people worldwide, predominantly in populations of African, Middle Eastern and South Asian descent. Pfizer will continue to build on the companies’ shared commitment to and engagement with the SCD community.

    Additional Transaction Details

    Pfizer has completed its acquisition of all the outstanding shares of common stock of GBT for $68.50 per share in cash for an estimated total enterprise value of approximately $5.4 billion, including debt and net of cash acquired. GBT is now a wholly owned subsidiary of Pfizer. In connection with the acquisition, GBT’s shares of common stock ceased trading on the NASDAQ Global Select Market.

    Pfizer release

    Latest in Sourcing & Logistics

    Photo 177137895 © Mustsansar Syed | Dreamstime.com
    Sourcing & Logistics

    Biden Administration Announces New Actions to Strengthen Medical Supply Chain

    Nov. 28, 2023
    Photo 37130625 © Tyler Olson | Dreamstime.com
    Sourcing & Logistics

    One Expert Shares his View on the Future of Health System Supply Chain

    Mark Hagland
    Nov. 28, 2023
    Sourcing & Logistics

    Leadership Lessons from the Bellwether League Foundation

    Karen Conway
    Nov. 28, 2023
    219331233 © Iurii Motov, 133631119 © Viktoriia Kotova | Dreamstime.com
    Sourcing & Logistics

    Clinging to customer service amid cost containment

    Rick Dana Barlow
    Nov. 28, 2023
    167787822, 234990480 © Senkumar Alfred, 85689632 © Ruslan Olinchuk | Dreamstime.com
    Sourcing & Logistics

    From Vendor to Industry Partner: The Evolving Role in Healthcare

    Karen Niven
    Nov. 28, 2023
    Healthcare Purchasing News
    https://www.facebook.com/hpnonline
    https://www.linkedin.com/company/healthcare-purchasing-news/
    https://twitter.com/HPN_Online
    • About Us
    • Contact Us
    • Advertise
    • Do Not Sell or Share
    • Privacy Policy
    • Terms & Conditions
    © 2023 Endeavor Business Media, LLC. All rights reserved.
    Endeavor Business Media Logo